Somerset Hematology Oncology Associates - Somerville Location — East Brunswick, New Jersey

Somerset Hematology Oncology Associates - Somerville Location is a clinical research site located in East Brunswick, New Jersey, United States 8816.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Somerset Hematology Oncology Associates - Somerville Location has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.

Sponsors: EMD Serono Research & Development Institute, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Brunswick

Browse all research sites in New Jersey · View every site in East Brunswick

• Astera Cancer Care
• Astera Cancer Care East Brunswick
• Research Site
• START New Jersey
• UniMed Center
• Regional Cancer Care Associates
• START, Astera
• Titan Health Partners LLC, d/b/a Astera Cancer Care /ID# 221003
• Central Jersey Oncology Center
• Astera Cancer Center
• GSK Investigational Site
• Regional Cancer Care Associates, Central Jersey Division

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Somerset Hematology Oncology Associates - Somerville Location?

Somerset Hematology Oncology Associates - Somerville Location has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Somerset Hematology Oncology Associates - Somerville Location conducted?

Somerset Hematology Oncology Associates - Somerville Location has 1 clinical trials on record, with 1 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.

Is Somerset Hematology Oncology Associates - Somerville Location accredited by Crixeo Clinical Trials?

Somerset Hematology Oncology Associates - Somerville Location has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Somerset Hematology Oncology Associates - Somerville Location?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.